Comparison of diagnostic performances of different serological tests for SARS‐CoV‐2 antibody detection in cats and dogs. Issue 6 (13th October 2022)
- Record Type:
- Journal Article
- Title:
- Comparison of diagnostic performances of different serological tests for SARS‐CoV‐2 antibody detection in cats and dogs. Issue 6 (13th October 2022)
- Main Title:
- Comparison of diagnostic performances of different serological tests for SARS‐CoV‐2 antibody detection in cats and dogs
- Authors:
- Ratti, Gabriele
Lelli, Davide
Moreno, Ana
Stranieri, Angelica
Trogu, Tiziana
Giordano, Alessia
Grassi, Andrea
Luzzago, Camilla
Decaro, Nicola
Paltrinieri, Saverio
Lauzi, Stefania - Abstract:
- Abstract: Serosurveillance among animals, including pets, plays an important role in the current coronavirus disease 2019 (COVID‐19) pandemic, because severe acute respiratory coronavirus 2 (SARS‐CoV‐2) infections in animal populations could result in the establishment of new virus reservoirs. Serological assays that offer the required sensitivity and specificity are essential. In this study, we evaluated the diagnostic performance of three different commercially available immunoassays for the detection of SARS‐CoV‐2 antibodies in pets, namely two ELISA tests for the detection of antibodies against SARS‐CoV‐2 nucleocapsid [ID Screen SARS CoV‐2 double antigen multispecies (Double antigen) and ID Screen® SARS‐CoV‐2‐N IgG indirect ELISA (Indirect)] and one test for the detection of neutralizing antibodies against SARS‐CoV‐2 receptor‐binding‐domain [surrogate virus neutralization test (sVNT)]. The obtained results were compared with those of conventional virus neutralization test (VNT), which was regarded as reference method. A total of 191 serum samples were analysed. Thirteen (6.8%) samples showed VNT‐positive results. The overall sensitivity was higher for sVNT (100%) compared to nucleocapsid‐based ELISA assays (23% for Double antigen and 60% for Indirect). The specificity was 100% for Indirect ELISA and sVNT, when a higher cut‐off (>30%) was used compared to the one previously defined by the manufacturer (>20%), whereas the other test showed lower value (99%). The sVNT testAbstract: Serosurveillance among animals, including pets, plays an important role in the current coronavirus disease 2019 (COVID‐19) pandemic, because severe acute respiratory coronavirus 2 (SARS‐CoV‐2) infections in animal populations could result in the establishment of new virus reservoirs. Serological assays that offer the required sensitivity and specificity are essential. In this study, we evaluated the diagnostic performance of three different commercially available immunoassays for the detection of SARS‐CoV‐2 antibodies in pets, namely two ELISA tests for the detection of antibodies against SARS‐CoV‐2 nucleocapsid [ID Screen SARS CoV‐2 double antigen multispecies (Double antigen) and ID Screen® SARS‐CoV‐2‐N IgG indirect ELISA (Indirect)] and one test for the detection of neutralizing antibodies against SARS‐CoV‐2 receptor‐binding‐domain [surrogate virus neutralization test (sVNT)]. The obtained results were compared with those of conventional virus neutralization test (VNT), which was regarded as reference method. A total of 191 serum samples were analysed. Thirteen (6.8%) samples showed VNT‐positive results. The overall sensitivity was higher for sVNT (100%) compared to nucleocapsid‐based ELISA assays (23% for Double antigen and 60% for Indirect). The specificity was 100% for Indirect ELISA and sVNT, when a higher cut‐off (>30%) was used compared to the one previously defined by the manufacturer (>20%), whereas the other test showed lower value (99%). The sVNT test showed the highest accuracy and agreement with VNT, with a perfect agreement when the higher cut‐off was applied. The agreement between each nucleocapsid‐based ELISA test and VNT was 96% for Indirect and 94% for Double antigen. Our findings showed that some commercially available serological tests may lead to a high rate of false‐negative results, highlighting the importance of assays validation for the detection of SARS‐CoV‐2 antibodies in domestic animals. … (more)
- Is Part Of:
- Transboundary and emerging diseases. Volume 69:Issue 6(2022)
- Journal:
- Transboundary and emerging diseases
- Issue:
- Volume 69:Issue 6(2022)
- Issue Display:
- Volume 69, Issue 6 (2022)
- Year:
- 2022
- Volume:
- 69
- Issue:
- 6
- Issue Sort Value:
- 2022-0069-0006-0000
- Page Start:
- 3530
- Page End:
- 3539
- Publication Date:
- 2022-10-13
- Subjects:
- cats -- diagnostic tests accuracy -- dogs -- immunological assay -- serosurveillance -- severe acute respiratory coronavirus 2
Veterinary medicine -- Periodicals
636.089 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1865-1682 ↗
http://www3.interscience.wiley.com/journal/118541580/home ↗
http://www.blackwell-synergy.com/rd.asp?goto=journal&code=jva ↗
https://www.hindawi.com/journals/schm/contents/ ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/tbed.14716 ↗
- Languages:
- English
- ISSNs:
- 1865-1674
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9020.570100
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25765.xml